iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Lupin gets USFDA approval for nasal spray; stock trades higher

4 Jul 2023 , 12:00 PM

Lupin’s stock rose more than 1% in early trade on July 4 after the company received approval from the US Food and Drug Administration (USFDA) for nasal spray.

At around 11.53 AM, Lupin was trading at Rs 895.60, up by 0.37%, against the previous close of Rs 892.30 on NSE. The counter rose to an intraday high of Rs 902.90.

The FDA has granted Lupin approval for its abbreviated new drug application for a nasal spray containing Cyanocobalamin at a strength of 500 mcg per spray. This nasal spray is a generic version of Par Pharmaceutical, Inc.’s Nascobal Nasal Spray, which also contains 500 mcg of Cyanocobalamin per spray.

Lupin said that it will manufacture the product at its Somerset facility in the US.

As per IQVIA MAT data of March 2023, Cyanocobalamin Nasal Spray had an estimated annual sale of USD 69 million in the United States.

Last month, the company announced the launch of Rufinamide Oral Suspension, 40 mg/mL, a generic equivalent of Eisai Inc.’s Banzel Oral Suspension, 40 mg/mL.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • Lupin
  • Lupin News
  • Lupin Updates
  • Lupin USFDA Approval
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.